What is PriMed Pharmaceuticals?
Based in New Jersey, PriMed Pharmaceuticals operates as a NABP Accredited drug distributor, specifically engineered to address the procurement challenges faced by independent community pharmacies. By bypassing the conventional primary wholesaler model, the company provides a streamlined, cost-effective supply chain for generic medications. Their market position is defined by a commitment to personalized customer service, real-time pricing transparency, and proactive management of drug shortages. This operational focus allows independent pharmacies to maintain profitability while ensuring consistent access to essential pharmaceutical inventory, effectively bridging the gap between large-scale manufacturing and local patient care.
How much funding has PriMed Pharmaceuticals raised?
PriMed Pharmaceuticals has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PriMed Pharmaceuticals
PPP
Public-Private Partnership
What's next for PriMed Pharmaceuticals?
With the infusion of this latest financing, PriMed Pharmaceuticals is poised to accelerate its market penetration and enhance its logistical infrastructure. The strategic deployment of these funds will likely focus on scaling distribution capabilities and expanding the company's reach to a broader network of independent pharmacies. As the pharmaceutical sector continues to grapple with supply chain volatility, PriMed's emphasis on dependable, efficient supply solutions provides a robust foundation for long-term growth. Future initiatives will likely involve optimizing inventory management systems and strengthening partnerships with generic drug manufacturers to further insulate their clients from market fluctuations and pricing instability.
See full PriMed Pharmaceuticals company page
